Caprini Score in Venous Surgery: a Prospective Cohort Study

NCT ID: NCT03041805

Last Updated: 2025-01-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-01

Study Completion Date

2027-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to make a validation of Caprini score in patients undergoing varicose veins surgery, especially endovascular procedures (endovascular laser treatment - EVLT, radiofrequency ablation - RFA, ultrasound-guided foam sclerotherapy - USFS) and to identify patients with elevated risk of postoperative venous thromboembolism (VTE) who will benefit from prophylactic anticoagulation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A prospective cohort study based on the platform of Ongoing Registry of Treatment of Chronic Venous Diseases (NCT03035747). The study will enrol adult patients undergoing any kind of varicose veins surgery with and without any prophylaxis. The patients should be examined for venous thromboembolic complications during 2-4 weeks after the procedure with mandatory duplex ultrasound.

The study will provide following information:

* the rate of asymptomatic DVT after varicose veins surgery
* the rate of symptomatic VTE after varicose veins surgery
* the rate of thermal-induced thrombosis (EHIT) after endovenous thermal ablation
* the ability of Caprini scores to predict VTE after varicose veins surgery
* identification of patients with high risk of VTE who will benefit from prophylaxis, especially with anticoagulation

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Venous Thromboembolism Varicose Veins

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EVLT

Endovenous laser treatment of great saphenous vein, small saphenous vein, accessorial saphenous vein with different laser wavelength and any bare type

Intervention Type PROCEDURE

RFA

Radiofrequency ablation of great saphenous vein, small saphenous vein, accessorial saphenous vein with ClosureFast technique

Intervention Type PROCEDURE

USFS

Ultrasound guided foam sclerotherapy of great saphenous vein, small saphenous vein, accessorial saphenous vein with polidocanol or tetradecyl sulphate of any concentration

Intervention Type PROCEDURE

HL/stripping

High ligation and stripping of great saphenous vein, small saphenous vein, accessorial saphenous vein

Intervention Type PROCEDURE

Miniphlebectomy

Miniphlebectomy of any varicose veins under local, regional or general anaesthesia

Intervention Type PROCEDURE

Sclerotherapy

Foam or liquid sclerotherapy of any varicose veins with polidocanol or tetradecyl sulphate of any concentration

Intervention Type PROCEDURE

GCS

Graduated compression stockings may be used after procedure by the decision of the doctor

Intervention Type DEVICE

LMWH

Low-molecular-weight heparin may be used after procedure by the decision of the doctor

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age over 18 years
* any kind of varicose vein surgery
* follow up for 4 weeks after the procedure
* examination for VTE at 2-4 weeks after the procedure, including duplex ultrasound

Exclusion Criteria

\- lost for follow-up during 4 weeks
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pirogov Russian National Research Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kirill Lobastov

Associated Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kirill Lobastov, PhD

Role: STUDY_CHAIR

Pirogov Russian National Research Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pirogov Russian National Research Medical University

Moscow, , Russia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Russia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kirill Lobastov, PhD

Role: CONTACT

+7-985-211-63-31

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kirill Lobastov, PhD

Role: primary

+7-985-211-63-31

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CAPSIVS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.